These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11976718)

  • 1. A role for Toll in autoimmunity.
    Krieg AM
    Nat Immunol; 2002 May; 3(5):423-4. PubMed ID: 11976718
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.
    Rui L; Vinuesa CG; Blasioli J; Goodnow CC
    Nat Immunol; 2003 Jun; 4(6):594-600. PubMed ID: 12740574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?
    Lenert P
    Clin Exp Immunol; 2005 Apr; 140(1):1-10. PubMed ID: 15762869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Toll for lupus.
    Anders HJ
    Lupus; 2005; 14(6):417-22. PubMed ID: 16038103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R; Roberts TL; Stacey KJ; Lenert P
    Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in immunostimulatory CpG oligonucleotides.
    Rothenfusser S; Tuma E; Wagner M; Endres S; Hartmann G
    Curr Opin Mol Ther; 2003 Apr; 5(2):98-106. PubMed ID: 12772497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology: DNA drives autoimmunity.
    Vinuesa CG; Goodnow CC
    Nature; 2002 Apr; 416(6881):595-8. PubMed ID: 11948338
    [No Abstract]   [Full Text] [Related]  

  • 10. TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
    Latz E; Schoenemeyer A; Visintin A; Fitzgerald KA; Monks BG; Knetter CF; Lien E; Nilsen NJ; Espevik T; Golenbock DT
    Nat Immunol; 2004 Feb; 5(2):190-8. PubMed ID: 14716310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.
    Lenert P; Brummel R; Field EH; Ashman RF
    J Clin Immunol; 2005 Jan; 25(1):29-40. PubMed ID: 15742155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.
    Rutz M; Metzger J; Gellert T; Luppa P; Lipford GB; Wagner H; Bauer S
    Eur J Immunol; 2004 Sep; 34(9):2541-50. PubMed ID: 15307186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM; Vollmer J
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling in B cells via Toll-like receptors.
    Peng SL
    Curr Opin Immunol; 2005 Jun; 17(3):230-6. PubMed ID: 15886111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology. Discriminating microbe from self suffers a double toll.
    Goodnow CC
    Science; 2006 Jun; 312(5780):1606-8. PubMed ID: 16778043
    [No Abstract]   [Full Text] [Related]  

  • 16. B-cell tolerance checkpoints in health and autoimmunity.
    Meffre E; Wardemann H
    Curr Opin Immunol; 2008 Dec; 20(6):632-8. PubMed ID: 18848883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
    Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
    Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell biology.
    Weinstein E; Peeva E; Putterman C; Diamond B
    Rheum Dis Clin North Am; 2004 Feb; 30(1):159-74. PubMed ID: 15061573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.